Aigen Investment Management, LP Medpace Holdings, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$227.52 - $312.68 $258,917 - $355,829	1,138 New	1,138 $348,000
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $125,651 - $161,154	-671 Reduced 35.2%	1,235 $296,000
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $106,852 - $146,825	613 Added 47.41%	1,906 $358,000
Q4 2022 Feb 10, 2023	BUY	$153.06 - $226.57 $197,906 - $292,955	1,293 New	1,293 $274,000
Q1 2020 May 08, 2020	SELL	$61.71 - $101.95 $524,966 - $867,288	-8,507 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$70.08 - $84.64 $596,170 - $720,032	8,507 New	8,507 $715,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.